CICC QIDE
CICC QIDE
Status:
Active
Similar Organizations
BAI Capital
BAI Capital is an investment arm of German media mogul Bertelsmann.
Dongqi Qiye
Dongqi Qiye is an investment management firm.
Invexor Capital
Invexor Capital is an investment management firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-09 | AMCARELAB | CICC Qide investment in Series B - AMCARELAB | 200 M CNY |
| 2022-03-03 | CytoNiche | CICC Qide investment in Series B - CytoNiche | 300 M CNY |
| 2022-01-10 | Bo Shengji | CICC Qide investment in Series B - Bo Shengji | N/A |
| 2021-12-23 | Innogen Pharmaceutical | CICC Qide investment in Series A - Innogen Pharmaceutical | 120 M USD |
| 2021-12-03 | LePure Biotech | CICC Qide investment in Series B - LePure Biotech | N/A |
| 2021-11-10 | Changmugu Medical | CICC Qide investment in Series B - Changmugu Medical | 540 M CNY |
| 2021-03-17 | Akang health | CICC Qide investment in Series B - Akang health | 200 M CNY |
| 2020-12-10 | Denovo Biopharma | CICC Qide investment in Series D - Denovo Biopharma | 300 M CNY |
| 2020-08-25 | Sinovent | CICC Qide investment in Series C - Sinovent | 1000 M CNY |
| 2020-07-01 | CF PharmTech | CICC Qide investment in Series F - CF PharmTech | 360 M CNY |
More informations about "CICC Qide"
CICC Qide - Crunchbase Investor Profile & Investments
CICC Qide is an investment management firm.See details»
CICC Qide - Investments, Portfolio & Company Exits - Crunchbase
CICC Qide has invested in Denovo Biopharma on May 11, 2024. This investment - Series D - Denovo Biopharma - was valued at . obfuscated. obfuscated. ... Which industries has this …See details»
CICC Qide Innovation Biopharmaceutical Equity Investment Fund
Dec 31, 2021 CICC Qide Innovation Biopharmaceutical Equity Investment Fund is a 2020 vintage venture capital fund managed by CICC Capital. The fund is located in Beijing, China, …See details»
Chinese PE Fund Manager CICC Capital Secures $649m ... - Caixin …
Jan 14, 2021 CICC Capital, the private equity (PE) fund management platform of Hong Kong-listed investment bank CICC, has reached the second closing of its biomedicine fund at over …See details»
Boshengji Targeting B7-H3 Chimeric Antigen Receptor T Cell
Dec 13, 2024 According to the definition given by the World Health Organization (WHO), rare diseases refer to the number of patients with 0.65‰-1‰ of the total population. In the United …See details»
CICC Qide - raizer.app
CICC Qide is an investment management firm. Learn which startups CICC Qide invests in, number of investmenst, exits, and contact info to pitch your startup.See details»
CICC Has Second Close of Biomedical Fund at $648 Million
Jan 14, 2021 CICC Capital announced its RMB biomedical private equity fund, called CICC Qide, has raised $648 million as of the second closing. In February of 2020, CICC announced …See details»
Series B - Yaohai Bio - 2022-11-21 - Crunchbase
Nov 21, 2022 Organization Name . Yaohai Bio . Announced Date Nov 21, 2022; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . CN¥100M. Lead Investors. Edit …See details»
CICC Qide — 17 Investments, Portfolio, Team members — Unicorn …
CICC Qide. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom list of funds. …See details»
China’s CICC raises $650m for biomedical fund - AVCJ
Nov 10, 2023 CICC Capital has reached a second close of RMB4.2 billion ($650 million) on its latest healthcare fund - the first in China to receive fast-track approval for its role in addressing …See details»
Ribo raised 470 million yuan in its Series C2 financing
CICC Qide Fund has become a leading RMB biomedical fund during the past few years. About GL Ventures . A subsidiary of Hillhouse Capital Group, GL Ventures is a venture capital fund …See details»
Chinese PE fund manager CICC Capital secures $649m second …
Jan 12, 2021 CICC Capital, the private equity (PE) fund management platform of Hong Kong-listed investment bank CICC, has reached the second closing of its biomedicine fund at over …See details»
"Qichensheng" completed several hundred million yuan of pre-A …
May 31, 2021 Qichensheng has recently completed several hundred million yuan of pre-A + round financing. The current round of financing is led by the CICC Qide innovative biomedical …See details»
CICC Capital raises CNY1.6bn - Private Equity International
Feb 19, 2020 Fund name: CICC Qide Xiamen Innovative Biomedical Fund Amount raised: CNY1.6 billion Target size: CNY1.5 billion Stage of fundraising: First close CICC Capital has …See details»
DealShot: 13 Deals Breaking $220 Million Counting CDH …
Feb 21, 2022 DealShot: 13 Deals Breaking $220 Million Counting CDH Investments, CICC Qide And Many More. Katherine Guo February 21, 2022 — 17:56 CST UNLOCK DATA Subscribe …See details»
Series B - CytoNiche - 2022-03-03 - Crunchbase Funding Round …
Mar 3, 2022 Organization Name . CytoNiche . Announced Date Mar 3, 2022; Closed On Date Mar 3, 2022; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . ...See details»
CICC raises $229m for China healthcare fund - AVCJ
Nov 10, 2023 China's CICC Capital has raised RMB1.6 billion ($229 million) for its first fund dedicated to the biopharmaceutical space. The CICC Qide Innovative Biopharmaceutical …See details»
2022-2025 Strategic Plan - cicc.ca
CICC developed a Strategic Plan for the period of 2022-2025. The planning process, which took place between November 2021 and May 2022, gathered feedback from families, community …See details»
Synaura - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . May 11, 2024: Seed Round - …See details»
Welcome to the College
The College of Immigration and Citizenship Consultants is the regulatory body that licenses immigration and citizenship consultants to protect the public.See details»